Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression

Authors not listed

Center for Eye Research Australia · 2021

Abstract

Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss worldwide, and nearly two million Australians have some signs of AMD. This proposed project is a prospective, observational study that seeks to to understand the underlying aetiology of AMD, factors associated with differences between age-related macular degeneration (AMD) phenotypes or severities, or between AMD and healthy individuals. It also seeks to understand the natural history of AMD progression and the factors associated with the rate of progression. In this project, the disease phenotype, genotype and severity and rate of progression will be determined based on non-invasive clinical imaging or functional assessment of the retina, from obtaining biological samples from the participants, or from patient-reported outcomes.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2021). Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression. <em>Center for Eye Research Australia</em>. https://clinicaltrials.gov/study/NCT04739319
Vancouver
Anonymous. Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression. Center for Eye Research Australia. 2021.
BibTeX
@misc{anon2021Projec, title = {Project AMD: Comprehensive Characterisation of Age-Related Macular Degeneration and Its Progression}, author = {Anonymous}, journal = {Center for Eye Research Australia}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings